Semaglutide could help prevent alcohol-use disorder
-
"Novo Nordisk's semaglutide has racked up several clinical wins demonstrating the GLP-1 receptor agonist's benefit goes beyond just weight loss, with the most recent data showing the drug can reduce mortality in patients with type 2 diabetes and chronic kidney disease, while earlier findings cemented its ability to reduce major adverse cardiovascular events.
Now, a new study suggests it may be able to help people who suffer from alcohol-use disorder (AUD)".
Read more: https://firstwordpharma.com/story/5861815
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind